e-learning
resources
European Respiratory Review
2021
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Antibiotics as immunomodulators: a potential pharmacologic approach for ARDS treatment
Andrea Sauer, Konrad Peukert, Christian Putensen, Christian Bode
Source:
Eur Respir Rev, 30 (162) 210093; 10.1183/16000617.0093-2021
Journal Issue:
December
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Andrea Sauer, Konrad Peukert, Christian Putensen, Christian Bode. Antibiotics as immunomodulators: a potential pharmacologic approach for ARDS treatment. Eur Respir Rev, 30 (162) 210093; 10.1183/16000617.0093-2021
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Risk factors of adverse outcome after acute hospitalization in Idiopathic Pulmonary Fibrosis (IPF)
Related content which might interest you:
Treatment of COPD: from pharmacological to instrumental therapies
Source: Eur Respir Rev 2009; 19: 7-23
Year: 2010
Therapeutic strategies in pneumonia: going beyond antibiotics
Source: Eur Respir Rev 2015; 24: 516-524
Year: 2015
Do we have any alternative therapeutic option beyond antibiotics?
Source: Postgraduate course 2021: PG7 - Postgraduate course : Emerging infectious diseases and antimicrobial resistance: diagnostics, treatments, vaccines and other preventive and/or therapeutic interventions
Year: 2021
Update on novel anticoagulants: indications, dosing alternatives and outcomes
Source: International Congress 2018 – Pulmonary embolism: what we need to know
Year: 2018
Which patients with COPD can potentially benefit from prophylactic use of antibiotics?
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007
Therapeutic options for sarcoidosis: old and new
Source: Annual Congress 2005 - PG15 - Therapeutic options for interstitial lung diseases in 2005
Year: 2005
Corticosteroids as adjunctive therapy in tuberculosis pneumonia with ART
Source: Breathe 2008; 5: 274
Year: 2009
A new combination therapeutic approach challenging the current dogma of using inhaled corticosteroids as maintenance only to control asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 666s
Year: 2006
Current approaches to the prevention of tuberculosis in patients receiving immunosuppressants
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021
Chronic cough: Are we integrating non-pharmacological therapies into treatment plans?
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017
Inhalations of ultra-low doses of alkylating drug for the treatment of steroid-dependant asthma: anti-inflammatory effect of therapy
Source: Eur Respir J 2001; 18: Suppl. 33, 266s
Year: 2001
Non-antibiotic therapies for CAP
Source: Eur Respir Monogr 2014; 63: 219-233
Year: 2014
Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD?
Source: Eur Respir J, 54 (4) 1901597; 10.1183/13993003.01597-2019
Year: 2019
Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD?
Source: Eur Respir J, 54 (4) 1901405; 10.1183/13993003.01405-2019
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept